Photocatalytic Conversion of Aminocyclopropanes to γ‑Lactams by Sequential Ring-Expansion and Peripheral Diversification

Created on 07.20

JACS article title on photocatalytic conversion of aminocyclopropanes to γ-lactams via ring-expansion.

General photocatalytic system for synthesizing N- and γ-substituted γ-lactams with high yield and selectivity.

1. English Official Research Brief (Global Website Version)

Cyclic frameworks are fundamental structural backbones of pharmaceuticals, agrochemicals and functional materials. Skeletal ring expansion serves as a powerful skeleton-editing strategy that directly remodels existing cyclic structures and avoids tedious de novo synthesis. However, most established ring-expansion methodologies only enable single-atom insertion, lacking a versatile catalytic platform capable of sequential multi-atom insertion coupled with peripheral functionalization of the ring scaffold.
γ-Lactams, five-membered nitrogen heterocycles, exhibit prominent biological activity, yet conventional synthetic routes struggle to achieve efficient and selective diversification at the γ-position. Although radical ring-opening chemistry of aminocyclopropanes has been well-established, it has not been exploited to construct polysubstituted γ-lactams via tandem carbonylation and cyclization.
To address these persistent synthetic bottlenecks, the research group led by Professors Wen-Jing Xiao and Jia-Rong Chen at Central China Normal University established a tunable visible-light photocatalytic multicomponent platform utilizing iridium photocatalysts and organic photosensitizer 4CzIPN. Starting from aminocyclopropanes, carbon monoxide (CO) and various radical trapping reagents, the system proceeds through a photoredox-mediated radical cascade process to realize sequential single C and N atom [n+2] ring expansion, converting strained three-membered aminocyclopropanes into γ-lactams in a single operation.
Iridium photocatalysts efficiently drive two core transformations: Giese addition and Minisci heteroarylation. By simply switching photosensitizers, additives and radical acceptors, six types of peripheral γ-functionalization can be further achieved, including alkynylation, acylation, alkenylation and thiolation. The practicality of this methodology is validated via broad substrate scope screening, gram-scale synthesis and derivatization of pharmaceutical molecules. Comprehensive mechanistic insights are obtained through radical trapping experiments, in-situ EPR characterization and DFT theoretical calculations. This work delivers a modular new strategy for simultaneous skeleton editing and peripheral diversification of highly strained small rings.

2. Six Modular Photocatalytic Transformation Modes Supported by Iridium Catalysts

Class I: Giese Addition (Alkyl Functionalization at γ-Site)

  • Optimal Photocatalyst: Ir-1, Ir(ppy)₂(dtbbpy)PF₆ (CAS: 676525-77-2)
  • Reaction Setup: 80 atm CO, 2×3 W blue LEDs (λmax=456 nm), 48 h reaction time
  • Substrate Compatibility: Diverse aliphatic/aromatic alkenes, multisubstituted aminocyclopropanes, substrates bearing halogens, trifluoromethyl, alkoxy, ester, silyl alkyne and thioether groups
  • Performance: Most substrates deliver moderate to excellent yields (32%–94%), compatible with 5.0 mmol gram-scale preparation with negligible yield attenuation

Class II: Minisci Heteroarylation (N-Heterocycle Decoration at γ-Site)

  • Optimal Photocatalyst: Ir-2, Ir[dF(CF₃)ppy]₂(dtbbpy)PF₆ (CAS: 870987-63-6)
  • Key Additive: (NH₄)₂S₂O₈ oxidant, CF₃CO₂H acid additive
  • Substrate Scope: Pyridines, quinolines, isoquinolines and other azine heterocycles; biologically relevant molecular derivatization (Fasudil, Varenicline, Famciclovin, Cinchonine)
  • Advantage: Fluorinated iridium complex displays superior tolerance to acidic media and oxidants, suitable for complex drug-related heterocyclic building blocks

Class III: Alkynylation via EBX Reagents

  • Optimized Catalyst System: 4CzIPN + K₂CO₃ (alternative to iridium catalysts for higher yield)
  • Radical Precursor: Ethynyl benziodoxolone (EBX) alkynylation reagents with varied silyl/aryl/alkyl substituents
  • Synthetic Utility: Enables installation of TIPS, TMS, alkyl and aryl alkynyl groups, readily derivatizable fenofibrate analogues

Class IV: Acylation with Acyl Imidazole Electrophiles

  • Photosensitizer: 4CzIPN, NHC-P1 co-ligand, K₂CO₃ base
  • Electrophile Library: Aromatic, aliphatic, heteroaromatic acyl imidazoles with electron-donating/withdrawing substituents
  • Mechanism: Single electron transfer (SET) mediated acyl radical generation for selective γ-acylation

Class V: Alkenylation with Vinyl Sulfone Reagents

  • Catalyst: Ru(bpy)₃Cl₂ (complementary to iridium photocatalysts)
  • Substrate Suitability: Linear/branched vinyl sulfones, heteroaryl-tethered alkenyl precursors, wide aminocyclopropane functional group tolerance

Class VI: Thiolation via Disulfide & Thiosulfonate Reagents

  • Standard Photosensitizer: 4CzIPN, DBU base additive
  • Radical Source: Aryl disulfides, alkyl thiosulfonates, cycloalkyl sulfur reagents
  • Scalability: 0.6 mmol medium-scale reaction maintained moderate to good yields

3. Core Advantages of Iridium Photocatalysts in This Platform

  1. Matched Redox Potentials to Initiate Rapid Radical Ring-Opening
The excited-state redox potential of Ir-1 and Ir-2 perfectly matches aminocyclopropane substrates, triggering single-electron oxidation to generate aminyl radical cations and rapidly drive three-membered ring cleavage. Compared with organic photosensitizer 4CzIPN, iridium complexes eliminate radical regeneration barriers and deliver drastically enhanced catalytic activity.
  1. Specialized Catalytic Performance for Two Core Reactions
  • Ir-1 achieves optimal efficiency for alkene Giese addition and effectively suppresses side byproduct formation;
  • Fluorinated Ir-2 exhibits outstanding resistance to acidic environments and oxidants, uniquely suited for Minisci heteroarylation with pharmaceutical heterocyclic substrates.
  1. Excellent Photothermal Stability for High-Pressure CO Carbonylation
Iridium coordination complexes possess robust light and thermal stability, resisting catalyst deactivation under long-term blue light irradiation within sealed high-pressure CO reaction vessels.
  1. Precise Selectivity Control to Suppress Competitive Side Pathways
The iridium catalytic center directs carbon radicals to preferentially capture CO, inhibiting undesired [3+2] cycloaddition side reactions, thus enabling highly selective sequential C/N dual-atom [n+2] ring expansion.
  1. High Compatibility for Modular Multi-Reaction Platform Construction
Iridium photocatalysts are compatible with buffer salts, protic acids and oxidants, and can synergize with organic photosensitizers to establish a universal catalytic platform supporting six categories of γ-position peripheral diversification.

4. Mechanism Investigation & DFT Computational Evidence

  1. Radical Trapping Experiments
Radical capture tests with PhSeSePh unambiguously detect the key alkylacyl radical intermediate via HRMS, verifying the radical cascade ring-opening-carbonylation pathway.
  1. In-Situ Time-Resolved EPR Spectroscopy
DMPO spin-trapping EPR measurements confirm the generation of carbon-centered radical intermediates under blue light irradiation; no EPR signal is observed under dark conditions, proving the photocatalytic radical mechanism.
  1. DFT Free Energy Calculations
Computational energy profiles reveal the thermodynamic favorability of 5-endo-trig cyclization over competitive 4-exo-trig cyclization. The transition state orbital interactions and bond length data quantitatively explain the high chemo- and regioselectivity of the ring-expansion cyclization step.

5. Synthetic Practicality Highlights

  • Mild visible-light reaction conditions, no precious metal stoichiometric reagents required;
  • Broad functional group tolerance: halogen, trifluoromethyl, cyano, ester, alkoxy, alkyne, sulfur, heteroaromatic substituents all well-compatible;
  • Gram-scale synthetic reproducibility without significant yield loss;
  • Direct derivatization of commercial drug skeletons to access novel bioactive γ-lactam analogues;
  • Modular design: switchable reaction modes only by adjusting photosensitizers and radical trapping

Join Our Community

We are trusted by over 2000+ clients. Join them and grow your business.

Contact Us